nonprofit logo

The Cholangiocarcinoma Foundation

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 205776861 ✦ Salt lake city, UT ✦ Designated as a 501(c)(3)

Overview

What is The Cholangiocarcinoma Foundation?

The Cholangiocarcinoma Foundation is a nonprofit organization situated in Salt Lake City, Utah. Its primary focus is on cholangiocarcinoma, a type of cancer, by participating in the International Cholangiocarcinoma Research Network. This global collaboration aims to enhance understanding of the disease's causes, prevention, detection, treatment, and prognosis, involving experts from various disciplines and research methods. The organization has established a robust research fellowship program to foster innovative scientific discoveries, providing awards to qualified researchers. The Cholangiocarcinoma Foundation's mission is to find a cure and improve the quality of life for patients suffering from cholangiocarcinoma.


Official website here: www.cholangiocarcinoma.org

Is The Cholangiocarcinoma Foundation legitimate?

The Cholangiocarcinoma Foundation is a legitimate nonprofit organization registered as a 501(c)(3) entity. The Cholangiocarcinoma Foundation submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $340,331
Professional Fundraising Fees: $0
Other Salaries and Wages: $1,487,019

For more financial information, click here


Official website here: www.cholangiocarcinoma.org

What is the mission statement of The Cholangiocarcinoma Foundation?

The Cholangiocarcinoma Foundation's mission is centered around finding a cure for cholangiocarcinoma and enhancing the quality of life for patients affected by this condition. To achieve this, the organization actively participates in the International Cholangiocarcinoma Research Network, a global collaboration of renowned institutions working together to enhance knowledge about the disease's etiology, prevention, detection, treatment, and prognosis. The network comprises experts from various disciplines who share a common passion for making significant scientific advancements to improve outcomes for cholangiocarcinoma patients. Furthermore, the foundation has established a robust program to support innovative scientific discovery through its research fellowship program, providing awards to qualified researchers.


Official website here: www.cholangiocarcinoma.org

Who is the CEO of The Cholangiocarcinoma Foundation?

Stacie Lindsey is the Coo of The Cholangiocarcinoma Foundation. The CEO's salary of The Cholangiocarcinoma Foundation is $135,414 and their total compensation is $138,285.


Official website here: www.cholangiocarcinoma.org

What is the revenue of The Cholangiocarcinoma Foundation?

The Cholangiocarcinoma Foundation's revenue in 2023 was $5,082,650.


Official website here: www.cholangiocarcinoma.org

Who are the executives of The Cholangiocarcinoma Foundation and what are their salaries?

The average compensation at The Cholangiocarcinoma Foundation during 2023 was $70,283. There are 26 employees and 196 volunteers at The Cholangiocarcinoma Foundation.

Here are 11 key members and their salaries (The Cholangiocarcinoma Foundation's CEO's salary is $135,414 and their total compensation is $138,285):

    Alli Ward (Coo)
  • Compensation: $148,814
  • Related: $0
  • Other: $2,188

    • Stacie Lindsey (Ceo/Founder) [Trustee/Director]
  • Compensation: $135,414
  • Related: $0
  • Other: $2,871

    • Teresa Delcorso-Ellmann (Chair) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Dean Meyer (Vice Chair) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Robert Russell (Secretary) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Daniel Blum (Treasurer) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Ross Green (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Patricia Maxin (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jason Scott (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jack Callaway (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Liz Warner (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.cholangiocarcinoma.org

    Where can I find the form 990 for The Cholangiocarcinoma Foundation?

    The The Cholangiocarcinoma Foundation’s most recent form 990 was submitted in 2023 and can be accessed here


    Official website here: www.cholangiocarcinoma.org

    Learn more at the official website: www.cholangiocarcinoma.org

    Mission Statement of The Cholangiocarcinoma Foundation

    The Cholangiocarcinoma Foundation is committed to finding a cure and enhancing the quality of life for individuals affected by cholangiocarcinoma. To accomplish this mission, the organization actively participates in the International Cholangiocarcinoma Research Network, a collaborative effort involving renowned institutions and experts from various disciplines. The network's primary goal is to advance understanding about cholangiocarcinoma, with a focus on its etiology, prevention, detection, treatment, and prognosis. This global initiative brings together dedicated professionals with diverse perspectives and research methods, who share a passion for making significant scientific advancements to improve outcomes for patients suffering from cholangiocarcinoma.

    In addition to its participation in the research network, The Cholangiocarcinoma Foundation also supports innovative scientific discovery through a robust research fellowship program. This program provides awards to qualified researchers, fostering groundbreaking discoveries in the field of cholangiocarcinoma. By offering this support, the foundation plays a crucial role in advancing medical knowledge and contributing to potential breakthroughs in the diagnosis and treatment of this disease. Overall, The Cholangiocarcinoma Foundation is dedicated to driving progress in the fight against cholangiocarcinoma, with the ultimate goal of improving the lives of those affected by this often under-researched and misunderstood cancer.

    Impact

    This information is meant to be a general summary of The Cholangiocarcinoma Foundation. Please take the time to review official sources before making any decisions based upon the content provided here.




    Thursday, August 15, 2024

    The Cholangiocarcinoma Foundation's impact lies in its relentless pursuit of finding a cure and enhancing the quality of life for individuals battling cholangiocarcinoma. The organization plays a pivotal role in the field of medical research by spearheading and actively participating in the International Cholangiocarcinoma Research Network. This global collaboration brings together esteemed research groups from renowned institutions worldwide to advance understanding of cholangiocarcinoma, covering aspects like etiology, prevention, detection, treatment, and prognosis.

    Moreover, The Cholangiocarcinoma Foundation has established a robust program to promote innovative scientific discoveries through its Research Fellowship Program. By providing new awards to qualified researchers, the foundation supports cutting-edge research initiatives aimed at making substantial scientific breakthroughs to benefit patients with cholangiocarcinoma.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2023.

  • Investment Income: $88,227
  • Program Service Revenue: $58,825
  • Gross Receipts: $5,188,683

    • Assets and Liabilities:
  • Total Assets: $4,624,165
  • Total Liabilities: $993,414
  • Net Assets: $3,630,751
  • Programs

    Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

    CONTRACT SERVICES

    Revenue

    $58,825

    Organization Details

    Founding Year

    2006

    Principal Officer

    Stacie Lindsey

    Main Address

    5526 WEST 13400 SOUTH STE 510, SALT LAKE CITY, UT, 84096

    NTEE Category

    Code: H99 - Medical research

    If you are a representative of The Cholangiocarcinoma Foundation and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.